{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:55:43Z","timestamp":1776135343079,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11739-021-02866-x","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T17:12:39Z","timestamp":1634317959000},"page":"25-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Perioperative management of antithrombotic therapy: a case-based narrative review"],"prefix":"10.1007","volume":"17","author":[{"given":"Andrew Tiger","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Demetrios","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"2866_CR1","unstructured":"ClinCalc DrugStats Database. https:\/\/clincalc.com\/DrugStats\/. Accessed 8 Jun 2021"},{"key":"2866_CR2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/heartjnl-2016-310581","volume":"104","author":"A Tafur","year":"2018","unstructured":"Tafur A, Douketis J (2018) Perioperative management of anticoagulant and antiplatelet therapy. Heart 104:1461\u20131467. https:\/\/doi.org\/10.1136\/heartjnl-2016-310581","journal-title":"Heart"},{"key":"2866_CR3","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1111\/j.1538-7836.2007.02729.x","volume":"5","author":"AS Dunn","year":"2007","unstructured":"Dunn AS, Spyropoulos AC, Turpie AGG (2007) Bridging therapy in patients on long-term oral anticoagulants who require surgery: the prospective peri-operative enoxaparin cohort trial (PROSPECT). J Thromb Haemost 5:2211\u20132218. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02729.x","journal-title":"J Thromb Haemost"},{"key":"2866_CR4","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/jth.14598","volume":"17","author":"AC Spyropoulos","year":"2019","unstructured":"Spyropoulos AC, Brohi K, Caprini J et al (2019) Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: recommendations for standardized reporting of procedural\/ surgical bleed risk and patient-specific. J Thromb Haemost 17:1966\u20131972. https:\/\/doi.org\/10.1111\/jth.14598","journal-title":"J Thromb Haemost"},{"key":"2866_CR5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMoa1501035","volume":"373","author":"JD Douketis","year":"2015","unstructured":"Douketis JD, Spyropoulos AC, Kaatz S et al (2015) Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 373:823\u2013833. https:\/\/doi.org\/10.1056\/NEJMoa1501035","journal-title":"N Engl J Med"},{"key":"2866_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.N1205","author":"MJ Kovacs","year":"2021","unstructured":"Kovacs MJ, Wells PS, Anderson DR et al (2021) Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. https:\/\/doi.org\/10.1136\/BMJ.N1205","journal-title":"BMJ"},{"key":"2866_CR7","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093\u20132104. https:\/\/doi.org\/10.1056\/NEJMoa1310907","journal-title":"N Engl J Med"},{"key":"2866_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891. https:\/\/doi.org\/10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"2866_CR9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151. https:\/\/doi.org\/10.1056\/NEJMoa0905561","journal-title":"N Engl J Med"},{"key":"2866_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJV et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992. https:\/\/doi.org\/10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"2866_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.hoc.2016.05.005","volume":"30","author":"BR Bell","year":"2016","unstructured":"Bell BR, Spyropoulos AC, Douketis JD (2016) Perioperative Management of the Direct Oral Anticoagulants: A Case-Based Review. Hematol Oncol Clin North Am 30:1073\u20131084","journal-title":"Hematol Oncol Clin North Am"},{"key":"2866_CR12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","volume":"179","author":"JD Douketis","year":"2019","unstructured":"Douketis JD, Spyropoulos AC, Duncan J et al (2019) Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med 179:1469\u20131478. https:\/\/doi.org\/10.1001\/jamainternmed.2019.2431","journal-title":"JAMA Intern Med"},{"key":"2866_CR13","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","volume":"39","author":"DH Birnie","year":"2018","unstructured":"Birnie DH, Healey JS, Wells GA et al (2018) Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). Eur Heart J 39:3973\u20133979. https:\/\/doi.org\/10.1093\/eurheartj\/ehy413","journal-title":"Eur Heart J"},{"key":"2866_CR14","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.jacc.2017.02.012","volume":"69","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Angiolillo DJ, Boden WE et al (2017) Use of antiplatelet therapy\/DAPT for Post-PCI patients undergoing noncardiac surgery. J Am Coll Cardiol 69:1861\u20131870","journal-title":"J Am Coll Cardiol"},{"key":"2866_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1160\/TH14-04-0305","volume":"113","author":"JD Douketis","year":"2015","unstructured":"Douketis JD, Healey JS, Brueckmann M et al (2015) Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure: substudy of the RE-LY trial. Thromb Haemost 113:625\u2013632. https:\/\/doi.org\/10.1160\/TH14-04-0305","journal-title":"Thromb Haemost"},{"key":"2866_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/rth2.12320","volume":"4","author":"JH Levy","year":"2020","unstructured":"Levy JH, Connors JM, Steiner ME et al (2020) Management of oral anticoagulants prior to emergency surgery or with major bleeding: a survey of perioperative practices in North America: communication from the scientific and standardization committees on perioperative and critical care haemostasis and thrombosis of the international society on thrombosis and haemostasis. Res Pract Thromb Haemost 4:562\u2013568. https:\/\/doi.org\/10.1002\/rth2.12320","journal-title":"Res Pract Thromb Haemost"},{"key":"2866_CR17","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/J.1538-7836.2008.03080.X","volume":"6","author":"E Jamula","year":"2008","unstructured":"Jamula E, DOUKETIS JD, SCHULMAN S, (2008) Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost 6:1615\u20131621. https:\/\/doi.org\/10.1111\/J.1538-7836.2008.03080.X","journal-title":"J Thromb Haemost"},{"key":"2866_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/J.THROMRES.2009.01.007","volume":"124","author":"E Jamula","year":"2009","unstructured":"Jamula E, Anderson J, Douketis JD (2009) Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis. Thromb Res 124:292\u2013299. https:\/\/doi.org\/10.1016\/J.THROMRES.2009.01.007","journal-title":"Thromb Res"},{"key":"2866_CR19","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"BL Di","year":"2014","unstructured":"Di BL, Burkhardt JD, Santangeli P et al (2014) Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management results from the role of coumadin in preventing thromboembolism in atrial fibrillation (AF) patients. Circulation 129:2638\u20132644. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.006426","journal-title":"Circulation"},{"key":"2866_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10840-016-0117-6","volume":"46","author":"P M\u00fcller","year":"2016","unstructured":"M\u00fcller P, Halbfass P, Sz\u00f6ll\u00f6si A et al (2016) Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation. J Interv Card Electrophysiol 46:203\u2013211. https:\/\/doi.org\/10.1007\/s10840-016-0117-6","journal-title":"J Interv Card Electrophysiol"},{"key":"2866_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1540-8167.2009.01603.x","volume":"21","author":"M Finlay","year":"2010","unstructured":"Finlay M, Sawhney V, Schilling R et al (2010) Uninterrupted warfarin for periprocedural anticoagulation in catheter ablation of typical atrial flutter: a safe and cost-effective strategy. J Cardiovasc Electrophysiol 21:150\u2013154. https:\/\/doi.org\/10.1111\/j.1540-8167.2009.01603.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2866_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0804-6","author":"M Brinkmeier-Theofanopoulou","year":"2018","unstructured":"Brinkmeier-Theofanopoulou M, Tzamalis P, Wehrkamp-Richter S et al (2018) Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants. BMC Cardiovasc Disord. https:\/\/doi.org\/10.1186\/s12872-018-0804-6","journal-title":"BMC Cardiovasc Disord"},{"key":"2866_CR23","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie DH, Healey JS, Wells GA et al (2013) Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 368:2084\u20132093. https:\/\/doi.org\/10.1056\/NEJMoa1302946","journal-title":"N Engl J Med"},{"key":"2866_CR24","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","volume":"126","author":"D Siegal","year":"2012","unstructured":"Siegal D, Yudin J, Kaatz S et al (2012) Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 126:1630\u20131639","journal-title":"Circulation"},{"issue":"27","key":"2866_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/S11239-008-0211-4","volume":"273","author":"G Denas","year":"2008","unstructured":"Denas G, Marzot F, Offelli P et al (2008) (2008) Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases. J Thromb Thrombolysis 273(27):340\u2013347. https:\/\/doi.org\/10.1007\/S11239-008-0211-4","journal-title":"J Thromb Thrombolysis"},{"issue":"24","key":"2866_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/S11239-007-0022-Z","volume":"242","author":"K Woods","year":"2007","unstructured":"Woods K, Douketis JD, Kathirgamanathan K et al (2007) Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. J Thromb Thrombolysis 242(24):93\u201397. https:\/\/doi.org\/10.1007\/S11239-007-0022-Z","journal-title":"J Thromb Thrombolysis"},{"key":"2866_CR27","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/J.1538-7836.2010.03781.X","volume":"8","author":"S Kaatz","year":"2010","unstructured":"Kaatz S, DOUKETIS JD, ZHOU H, et al (2010) Risk of stroke after surgery in patients with and without chronic atrial fibrillation. J Thromb Haemost 8:884\u2013890. https:\/\/doi.org\/10.1111\/J.1538-7836.2010.03781.X","journal-title":"J Thromb Haemost"},{"key":"2866_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.1994","volume":"2","author":"A Nogami","year":"2019","unstructured":"Nogami A, Harada T, Sekiguchi Y et al (2019) Safety and efficacy of minimally interrupted dabigatran vs uninterrupted warfarin therapy in adults undergoing atrial fibrillation catheter ablation: a randomized clinical trial. JAMA Netw open 2:e191994. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.1994","journal-title":"JAMA Netw open"},{"key":"2866_CR29","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jacep.2017.11.005","volume":"4","author":"MR Reynolds","year":"2018","unstructured":"Reynolds MR, Allison JS, Natale A et al (2018) A prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU trial. JACC Clin Electrophysiol 4:580\u2013588. https:\/\/doi.org\/10.1016\/j.jacep.2017.11.005","journal-title":"JACC Clin Electrophysiol"},{"key":"2866_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jjcc.2019.02.003","volume":"74","author":"R Nakamura","year":"2019","unstructured":"Nakamura R, Okishige K, Shigeta T et al (2019) Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation. J Cardiol 74:150\u2013155. https:\/\/doi.org\/10.1016\/j.jjcc.2019.02.003","journal-title":"J Cardiol"},{"key":"2866_CR31","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1253\/circj.CJ-19-0535","volume":"83","author":"N Takahashi","year":"2019","unstructured":"Takahashi N, Mukai Y, Kimura T et al (2019) Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation\u2014the prospective KYU-RABLE study. Circ J 83:2017\u20132024. https:\/\/doi.org\/10.1253\/circj.CJ-19-0535","journal-title":"Circ J"},{"key":"2866_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/rth2.12307","volume":"4","author":"Y Brennan","year":"2020","unstructured":"Brennan Y, Gu Y, Schifter M et al (2020) Dental extractions on direct oral anticoagulants vs. warfarin: the DENTST study. Res Pract Thromb Haemost 4:278\u2013284. https:\/\/doi.org\/10.1002\/rth2.12307","journal-title":"Res Pract Thromb Haemost"},{"key":"2866_CR33","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/europace\/euw409","volume":"19","author":"V Essebag","year":"2017","unstructured":"Essebag V, Proietti R, Birnie DH et al (2017) Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. Europace 19:1630\u20131636. https:\/\/doi.org\/10.1093\/europace\/euw409","journal-title":"Europace"},{"key":"2866_CR34","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.004","volume":"27","author":"DK Rose","year":"2018","unstructured":"Rose DK, Bar B (2018) Direct oral anticoagulant agents: pharmacologic profile, indications, coagulation monitoring, and reversal agents. J Stroke Cerebrovasc Dis 27:2049\u20132058","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2866_CR35","unstructured":"Douketis J (2021) Perioperative anticoagulant use for surgery evaluation study part 2 pilot . In: Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04192552?term=perioperative+bridging+anticoagulant&draw=2&rank=5. Accessed 28 Mar 2021"},{"key":"2866_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/rth2.12430","volume":"5","author":"JD Douketis","year":"2021","unstructured":"Douketis JD, Syed S, Li N et al (2021) A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant. Res Pract Thromb Haemost 5:159\u2013167. https:\/\/doi.org\/10.1002\/rth2.12430","journal-title":"Res Pract Thromb Haemost"},{"key":"2866_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000700","author":"S Narouze","year":"2018","unstructured":"Narouze S, Benzon HT, Provenzano D et al (2018) Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications (second edition): guidelines From the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. https:\/\/doi.org\/10.1097\/AAP.0000000000000700","journal-title":"Reg Anesth Pain Med"},{"key":"2866_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd012584.pub2","author":"SR Lewis","year":"2018","unstructured":"Lewis SR, Pritchard MW, Schofield-Robinson OJ et al (2018) Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.cd012584.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2866_CR39","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1056\/NEJMoa1507688","volume":"374","author":"PS Myles","year":"2016","unstructured":"Myles PS, Smith JA, Forbes A et al (2016) Stopping vs. continuing aspirin before coronary artery surgery. N Engl J Med 374:728\u2013737. https:\/\/doi.org\/10.1056\/NEJMoa1507688","journal-title":"N Engl J Med"},{"key":"2866_CR40","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","volume":"370","author":"PJ Devereaux","year":"2014","unstructured":"Devereaux PJ, Mrkobrada M, Sessler DI et al (2014) Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370:1494\u20131503. https:\/\/doi.org\/10.1056\/NEJMoa1401105","journal-title":"N Engl J Med"},{"key":"2866_CR41","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/ALN.0000000000003158","volume":"132","author":"DI Sessler","year":"2020","unstructured":"Sessler DI, Conen D, Leslie K et al (2020) One-year results of a factorial randomized trial of aspirin versus placebo and clonidine versus placebo in patients having noncardiac surgery. Anesthesiology 132:692\u2013701. https:\/\/doi.org\/10.1097\/ALN.0000000000003158","journal-title":"Anesthesiology"},{"key":"2866_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/bja\/aeq003","volume":"104","author":"A Oscarsson","year":"2010","unstructured":"Oscarsson A, Gupta A, redrikson M et al (2010) To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 104:305\u2013312. https:\/\/doi.org\/10.1093\/bja\/aeq003","journal-title":"Br J Anaesth"},{"key":"2866_CR43","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jamacardio.2016.3028","volume":"1","author":"R Gherli","year":"2016","unstructured":"Gherli R, Mariscalco G, Dal\u00e9n M et al (2016) Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in patients with acute coronary syndromes undergoing coronary artery bypass grafting. JAMA Cardiol 1:921\u2013928. https:\/\/doi.org\/10.1001\/jamacardio.2016.3028","journal-title":"JAMA Cardiol"},{"key":"2866_CR44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jama.2020.7840","volume":"324","author":"NR Smilowitz","year":"2020","unstructured":"Smilowitz NR, Berger JS (2020) Perioperative cardiovascular risk assessment and management for noncardiac surgery: a review. JAMA - J Am Med Assoc 324:279\u2013290","journal-title":"JAMA - J Am Med Assoc"},{"key":"2866_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jama.2011.2002","volume":"307","author":"DJ Angiolillo","year":"2012","unstructured":"Angiolillo DJ, Firstenberg MS, Price MJ et al (2012) Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 307:265\u2013274. https:\/\/doi.org\/10.1001\/jama.2011.2002","journal-title":"JAMA"},{"issue":"15","key":"2866_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrcardio.2017.223","volume":"155","author":"JH Levy","year":"2018","unstructured":"Levy JH, Douketis J (2018) Weitz JI (2018) Reversal agents for non-vitamin K antagonist oral anticoagulants. Nat Rev Cardiol 155(15):273\u2013281. https:\/\/doi.org\/10.1038\/nrcardio.2017.223","journal-title":"Nat Rev Cardiol"},{"key":"2866_CR47","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s12630-017-0868-2","volume":"64","author":"J Leitch","year":"2017","unstructured":"Leitch J, van Vlymen J (2017) Managing the perioperative patient on direct oral anticoagulants. Can J Anesth 64:656\u2013672. https:\/\/doi.org\/10.1007\/s12630-017-0868-2","journal-title":"Can J Anesth"},{"key":"2866_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ajem.2016.09.048","volume":"34","author":"JH Levy","year":"2016","unstructured":"Levy JH (2016) Discontinuation and management of direct-acting anticoagulants for emergency procedures. Am J Emerg Med 34:14\u201318","journal-title":"Am J Emerg Med"},{"key":"2866_CR49","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/ALN.0b013e318289bcba","volume":"118","author":"JH Levy","year":"2013","unstructured":"Levy JH, Faraoni D, Spring JL et al (2013) Managing new oral anticoagulants in the perioperative and intensive care unit setting. Anesthesiology 118:1466\u20131474","journal-title":"Anesthesiology"},{"key":"2866_CR50","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/j.1538-7836.2006.01815.x","volume":"4","author":"MW Lankiewicz","year":"2006","unstructured":"Lankiewicz MW, Hays J, Friedman KD et al (2006) Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 4:967\u2013970. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01815.x","journal-title":"J Thromb Haemost"},{"key":"2866_CR51","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1111\/J.1538-7836.2006.01986.X","volume":"4","author":"F D, W A, M C,","year":"2006","unstructured":"F D, W A, M C, (2006) Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 4:1853\u20131863. https:\/\/doi.org\/10.1111\/J.1538-7836.2006.01986.X","journal-title":"J Thromb Haemost"},{"key":"2866_CR52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1056\/NEJMoa1707278","volume":"377","author":"CV Pollack","year":"2017","unstructured":"Pollack CV, Reilly PA, van Ryn J et al (2017) Idarucizumab for Dabigatran Reversal \u2014 Full Cohort Analysis. N Engl J Med 377:431\u2013441. https:\/\/doi.org\/10.1056\/NEJMoa1707278","journal-title":"N Engl J Med"},{"key":"2866_CR53","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(14)61685-8","volume":"385","author":"JN Goldstein","year":"2015","unstructured":"Goldstein JN, Refaai MA, Milling TJ et al (2015) Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet 385:2077\u20132087. https:\/\/doi.org\/10.1016\/S0140-6736(14)61685-8","journal-title":"Lancet"},{"key":"2866_CR54","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","volume":"380","author":"SJ Connolly","year":"2019","unstructured":"Connolly SJ, Crowther M, Eikelboom JW et al (2019) Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med 380:1326\u20131335. https:\/\/doi.org\/10.1056\/NEJMoa1814051","journal-title":"N Engl J Med"},{"key":"2866_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25475","author":"A Cuker","year":"2019","unstructured":"Cuker A, Burnett A, Triller D et al (2019) Reversal of direct oral anticoagulants: guidance from the anticoagulation forum. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.25475","journal-title":"Am J Hematol"},{"key":"2866_CR56","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/jth.13305","volume":"14","author":"AC Spyropoulos","year":"2016","unstructured":"Spyropoulos AC, Al-Badri A, Sherwood MW, Douketis JD (2016) Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost 14:875\u2013885. https:\/\/doi.org\/10.1111\/jth.13305","journal-title":"J Thromb Haemost"},{"key":"2866_CR57","doi-asserted-by":"publisher","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA et al (2012) Perioperative management of antithrombotic therapy. Antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e326S-e350S. https:\/\/doi.org\/10.1378\/chest.11-2298","journal-title":"Chest"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-021-02866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-021-02866-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-021-02866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T11:08:17Z","timestamp":1644750497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-021-02866-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2866"],"URL":"https:\/\/doi.org\/10.1007\/s11739-021-02866-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"1 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"There was no involvement of patients or animal subjects in this work and research ethics board involvement was deemed to be unncessary.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}